Abstract
Introduction
The prognosis of MEN 1 patients is not only determined by pancreatic disease; it is also related to other uncommon tumors. The objective of this study is to analyze the tumors associated with MEN 1 outside the classic triad and to investigate their relationship with mortality.
Materials and methods
One hundred and five MEN 1 patients were studied in a tertiary referral hospital (1980–2019).
Results
With a follow-up of 11 ± 4 years, seven patients died (8%), four as a consequence MEN syndrome. Thirty-three percent had adrenal gland tumors. One patient died of adrenal cancer. Eight percent presented with a neuroendocrine thoracic neoplasm, and one patient died. Another patient died due to cutaneous T-cell lymphoma. A further patient died because of a gastrinoma with liver metastasis.
Conclusions
To conclude, 75% of MEN-related deaths were the result of an uncommon pathology, and we, therefore, recommend that these tumors should be taken into account in the screening and follow-up of these patients.
References
Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P et al (2010) Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surg 34:249–255
Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA, Norton JA (1998) Lethality of multiple endocrine neoplasia type I. World J Surg 22:581–586
Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR et al (2012) Endocrine Society. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97:2990–3011
Gatta-Cherifi B, Chabre O, Murat A, Niccoli P, Cardot-Bauters C, Rohmer V et al (2012) Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des tumeurs endocrines database. Eur J Endocrinol 166:269–279
Febrero B, Ríos A, Rodríguez JM (2017) Aggressive adrenal carcinoma in a young patient with multiple endocrine neoplasia 1 syndrome. Med Clin (Barc) 149:463
Goudet P, Murat A, Cardot-Bauters C, Emy P, Baudin E, du Boullay CH et al (2009) Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN 1 from the GTE (Groupe des Tumeurs Endocrines). World J Surg 33:1197–1207
Ye L, Wang W, Ospina NS, Jiang L, Christakis I, Lu J et al (2017) Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: a single-centre study, systematic review and meta-analysis. Clin Endocrinol (Oxf) 87(6):706–716
Yeh JE, Tahan SR, Burgin S (2017) Folliculin mutation-negative trichodiscomas in a patient with multiple endocine neoplasia type I syndrome. Dermatol Online J 23(8).
van Leeuwaarde RS, Dreijerink KM, Ausems MG, Beijers HJ, Dekkers OM, de Herder WW et al (2017) MEN1-dependent breast cancer: indication for early screening? results from the dutch MEN1 study group. J Clin Endocrinol Metab 102:2083–2090
Jhawar S, Lakhotia R, Suzuki M, Welch J, Agarwal SK, Sharretts J et al (2019) Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1. Endocrinol Diabetes Metab Case Rep 19:0040
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Research involving human participants
For this type of study, formal consent is not required.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Febrero, B., Segura, P., Ruiz-Manzanera, J.J. et al. Uncommon tumors in multiple endocrine neoplasia (MEN) type 1: Do they have a relationship with the prognosis of these patients?. J Endocrinol Invest 44, 1327–1330 (2021). https://doi.org/10.1007/s40618-020-01414-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-020-01414-2